For example, multiple metastases are induced by the VEGFR kinase inhibitor sunitinib/SU11248 or VEGFR-specific antibodies [6, 7], and the BRAF inhibitor PLX4720 induces metastasis in RAS- or BRAF-mutant melanoma [8]. This evidence concerns the gene BRAF and melanoma.